SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-070603
Filing Date
2024-06-07
Accepted
2024-06-07 16:05:15
Documents
11
Period of Report
2024-06-06
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K sana-20240606.htm   iXBRL 8-K 57727
  Complete submission text file 0000950170-24-070603.txt   182843

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sana-20240606.xsd EX-101.SCH 32067
14 EXTRACTED XBRL INSTANCE DOCUMENT sana-20240606_htm.xml XML 4892
Mailing Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39941 | Film No.: 241029277
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)